Thompson Davis & Co’s Revolution Medicines RVMD Stock Holding History

Thompson Davis & Co’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$236K	Buy	+1,150	New	+$228K	0.16%	125

Other funds holding RVMD

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Thompson Davis & Co's RVMD Position: Q3 2026 in Review

Thompson Davis & Co opened a new position in Revolution Medicines (RVMD) in Q3 2026: 1,150 shares worth $236K. The stake represents 0.16% of the portfolio and ranks #125 among its holdings.

490 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Thompson Davis & Co held 1,150 shares of Revolution Medicines worth $236K as of Q3 2026.
Revolution Medicines was a new Thompson Davis & Co position in Q3 2026.
Revolution Medicines made up 0.16% of Thompson Davis & Co's portfolio in Q3 2026, its #125 holding.
490 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Thompson Davis & Co's 13F filing for Q3 2026, filed 5 Nov 2026.